drugset / Trial / NCT00206622

Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes

NCT00206622

Phase 4 Completed 425 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

To determine the lowest effective dose of estradiol by comparing E2/LNG (2.2mg/0.69mg) and E2 (1.0mg) dose with placebo in decreasing the frequency and severity of moderate to severe hot flushes in postmenopausal women

Timeline

Start
2004-12
Primary completion
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estradiol Other / unclassified 1 mg Other
Comparator Estradiol Other / unclassified 2.2 mg Other
Comparator Levonorgestrel Small molecule 0.69 mg Other

Indications

No indication recorded.